ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

TO DETERMINE THE CLINICAL PRESENTATIONS OF INFLAMMATORY BOWEL DISEASE AMONG CHILDREN AT SERVICES HOSPITAL LAHORE

AUTHORS:

Dr. Muhammad Hamad, Dr Muhammad Awais, Dr Daud Ahmad khan

ABSTRACT:

Objective: To describe the clinical presentations of I.B.D. in the Jordanian pediatric age group. Place and Duration: In the Pediatric medicine Unit II of Services Hospital Lahore for two year duration from March 2017 to March 2019. Methods: Specially designed summary forms for medical records were filled with data collected from 36 patients presented at the Pediatric Gastroenterology OPD. All were diagnosed with IBD (Crohn's disease or ulcerative colitis). A thorough medical history, relevant clinical examination, laboratory tests and histopathological results were collected for all these patients. In addition to barium testing, thrombophilia detection and DEXA scan, they all had upper endoscopy and colonoscopy. Results: IBD was diagnosed in 36 patients. The age range was from 12 months to 14 years. The average age was 8 years. The ratio of men to women was 0.8: 1 (45% of men). In our study, ulcerative colitis was observed more frequently (51.6%). The most common symptoms are abdominal pain, weight loss and bloody diarrhea, respectively. On the other hand, the most common clinical symptom is delayed growth parameters. In our study, delayed bone age and osteoporosis were surprisingly high, and positive colonoscopy results were found in 32 patients (88%). Conclusion: Inflammatory bowel disease (I.B.D.) is rarely seen in young children in our country and is now increasingly defined in this age group. Female dominance was the most common admission symptoms, abdominal pain, weight loss, and bloody diarrhea. Growth inhibition was the most common clinical sign of the accessory intestine. Key words: inflammatory bowel disease, Crohn's disease, ulcerative colitis, child.

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.